Revenue Up 28% NPAT Up 40% EPS Up 33% Beat guidance on EBITDA by...

Revenue Up 28%
NPAT Up 40%
EPS Up 33%

Beat guidance on EBITDA by about 5%.

More of the same by a high quality company. Many ASX companies should study MNF as a blueprint on how to make considered, smart acquisition (without debt) that actually contribute to the growth of the company from the outset. EPS has increased five-fold in the 3 years, that says it all.

Few companies with well-regarded managers come out and say that they are "very confident" of strong growth ahead. That's what we have here.